Clinical Trial Update: Vorinostat in Treating Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the safety and efficacy of vorinostat in adults with acute myeloid leukemia, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Zolinza (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7) | Phase 2 | Status: COMPLETED | Results posted: 2013-05-16